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To examine whether Javanese ginseng root has an antihyperglycaemic effect, twenty-one male Rattus norvegicus rats were randomly divided 
into four groups: negative control (n= 3), positive control (n= 4), treatment (n= 7), and placebo (n= 7). Alloxan was injected intraperitoneally at a 
single dose of 80 mg/kg BW to rats to induce hyperglycaemia. Infusion of Javanese ginseng root or distilled water was given at a dose of 2% w/v 
solution with a volume of 1.8 mL/200 g BW per day for 14 days through an enteral feeding tube to either the treatment or placebo group, 
respectively. Blood glucose levels were measured using the colorimetric method. One-way analysis of variance (ANOVA) was used to examine 
differences in the mean of delta blood glucose (post intervention minus post alloxan blood glucose levels) among groups, followed by Tukey’s 
post hoc analysis. A P value < 0.05 was considered statistically significant. There was a significant difference (P= 0.0001) in delta blood glucose 
among groups. Post hoc analysis revealed that delta blood glucose in the treatment group (-102.99±2.26 mg/dL) was significantly (P= 0.0001) 
greater than in the placebo (2.45±0.29 mg/dL), positive control (3.05±0.70 mg/dL) and negative control (1.60±0.17 mg/dL) grou p. In conclusion, 
Javanese ginseng root has potential as a hypoglycemic agent in alloxan-induced diabetic animal models. 
____________________________________________________________________________________________________________________ 




Penelitian ini bertujuan mengetahui efek hipoglikemik akar ginseng jawa. Desain penelitian eksperimental pada 21 ekor tikus Rattus 
norvegicus, yang terbagi 4 kelompok, yaitu kontrol negatif (n= 3), kontrol positif (n= 4), perlakuan (n= 7) dan plasebo (n= 7). Aloksan diberikan 
secara injeksi intraperitoneal dengan dosis 80 mg/kg bobot badan untuk menginduksi hiperglikemia. Tujuh puluh dua jam kemudian, diberikan 
infusa akar ginseng jawa atau akuades dengan dosis 2% w/v dengan volume 1,8 mg/200 g bobot badan per hari selama 14 hari per sonde pada 
tikus coba kelompok perlakuan atau plasebo. Kadar glukosa darah diukur dengan metode kolorimetri. ANOVA satu arah dilakukan untuk 
menguji perbedaan delta kadar glukosa darah antar kelompok, yang dilanjutkan dengan uji post hoc Tukey. Nilai P<0,05 ditetapkan sebagai 
batas signifikasi. Terdapat perbedaan bermakna (P= 0,0001) delta kadar glukosa darah antar kelompok. Uji post hoc Tukey menunjukkan delta 
kadar glukosa darah kelompok perlakuan (-102,99±2,26 mg/dL) lebih rendah secara bermakna (P= 0,0001) daripada kelompok plasebo 
(2,45±0,29 mg/dL), kontrol positif (3,05±0,70 mg/dL), dan kontrol negatif (1,60±0,17 mg/dL). Disimpulkan bahwa akar ginseng jawa memiliki 
potensi sebagai agen hipoglikemia tikus model diabetes yang diinduksi dengan aloksan. 
____________________________________________________________________________________________________________________ 





Non-communicable diseases (NCD), also known as 
chronic diseases, are responsible for around 60% of 
human morbidity and mortality (Dans et al., 2011). 
Diabetes is among the big four of NCD, besides 
cardiovascular diseases (including ischemic heart 
disease and stroke), cancer, and chronic pulmonary 
diseases (such as obstructive pulmonary disease and 
asthma) (WHO, 2018). Despite treatment with oral 
hypoglycaemic drugs (for example metformin and 
glimepiride) and insulin, the prevalence of diabetes still 
increases. The International Diabetes Federation (IDF) 
reported that from 1980 to 2014, worldwide age-
standardized adult diabetes prevalence increased from 
4.3% (95% CI 2.4-7.0) to 9.0% (7.2-11.1) in men and 
from 5.0% (2.9-7.9) to 7.9% (6.4-9.7) in women. 
Moreover, IDF suggested that diabetes affects 
approximately 300 million people around the world, 
and that number is predicted to reach almost 450 
million by the year 2030 (NCD RiskC, 2016). 
Meanwhile, the number of adults with impaired glucose 
tolerance (IGT) will increase to almost 500 million by 
2030 (Hu, 2011). The devastating effects of diabetes 
cause significant cost-of-illness (COI), in which direct 
cost is higher than indirect costs. The direct cost 
portrays the cost of treatment, whereas the indirect 
costs represent the losses of productivity and earnings 
(Seuring et al., 2015).   
Diabetes mellitus is classified into four types: 1) 
type 1 diabetes mellitus (T1DM), which is caused by β-
cell destruction leading to absolute insulin deficiency; 
2) type 2 diabetes mellitus (T2DM), which is due to a 
progressive loss of β-cell of the pancreatic islets; 3) 
gestational diabetes; 4) specific types of diabetes due to 
other causes: neonatal diabetes, maturity-onset diabetes 
of the young (MODY), diseases of exocrine pancreas, 
and drug- or chemical-induced diabetes (such as 
glucocorticoid use, HIV/AIDS treatment, post organ 
transplantation) (ADA, 2019). In epidemiological 
studies, study subjects with diabetes can be defined as 
those having either fasting plasma glucose (FPG) of  
7.0 mmol/L or higher, history of diagnosis with 
diabetes, or insulin injection of oral hypoglycemic 
drugs (NCD RiskC, 2016).  
Ginseng has been recorded as one of the traditional 
medicinal herbs that have an anti-diabetic effect. The 
most common ginseng types that are most frequently 
used and studied are the Asian ginseng (Panax ginseng) 
and American ginseng (Panax quinquefolius L.). Both 
kinds of ginseng are reported to have hypoglycaemic 
effects in laboratory animals and humans.  In fact, the 
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effect of lowering blood glucose can be found in all its 
parts, such as roots, berries, and leaves (Chang et al., 
2013; Chen et al., 2019). 
Ginseng contains triterpenoid saponins, which are 
designated as ginsenosides. Ginsenosides are the major 
compounds of ginseng; therefore, they are often used as 
markers for the identification of ginseng. The 
molecular structure of ginsenoside is similar to that of 
steroids, which contains four rings known as 
cyclopentanoperhydrophenanthrene ring. Therefore, 
ginsenosides are written sometimes as steroidal 
saponins (Xie et al., 2005; Barret et al., 2019; Chen et 
al., 2019). 
Based on the chemical structure, ginsenosides are 
classified into the dammarane family and oleanane 
family. The dammarane family is divided into: 1) the 
protopanaxadiol (PPD) group, such as ginsenosides 
Rb1, Rb2, Rb3, Rd, Rc, Rg3, and Rh2; 2) the 
protopanaxatriol (PPT) group, such as ginsenosides 
Rg1, Rg2, Re, Rf, and Rh1. The oleanane family is, 
however, is the minority and contains only ginsenoside 
Ro (Chen et al., 2019). One other classification divides 
ginsenosides into large and small molecule 
ginsenosides. Small molecule ginsenosides, such as 
ginsenosides Rg3 and component K, are suggested to 
be more active than the large molecule ginsenosides, 
such as ginsenosides Rb, Rc, and Re (Chen et al., 
2014). 
In Indonesia, there is a succulent plant which slowly 
grows up to 100-120 cm tall and has pink flowers. The 
plant’s Latin name is Talinum paniculatum (Jacq.) 
Gaertn, and its roots swell in a similar manner to Panax 
ginseng root. Therefore, T. paniculatum is called 
Javanese ginseng (Thanamool et al., 2013; Manuhara et 
al., 2015; Santoso et al., 2016). T. paniculatum (Jacq.) 
Gertn has other names, such as T. patens (L) Wild, T. 
Carssifolium Wild, Portulaca patens, and T. reflexum 
Cav. As it belongs to the Portulacaceae family, T. 
paniculatum has a “sibling”: T. triangulare (Jacq.) 
Wild, which is traditionally called krokot belanda, and 
both are known as kolesom or som Java. This plant 
grows not only in Indonesia, but also in other parts of 
the world, especially in South East Asia. In Muangthai, 
it is called wan pak pang (Kohda et al., 1992; Santa 
and Prajogo, 1999; Thanamool et al., 2013).  
Javanese ginseng has been traditionally used to 
treat various health problems from inflammation of 
the skin, cough and inflammation of the lungs, 
gastrointestinal disorders such as diarrhea, 
reproductive problems such as irregular menstruation 
and vaginal discharge, and finally, to boost the 
production of breast milk. The anti-inflammatory and 
anti-oxidant activities of Javanese ginseng have been 
observed in both from the water extracts contained 
within it and the ethanolic extracts of its leaves 
(Lestario et al., 2009) and roots (Estiasih and 
Kurniawan, 2006). An in vitro study reported that 
phytosterols in Javanese ginseng leaf extract has anti-
microbial bioactivity.  They also possess a low 
cytotoxic effect (Dos Reis et al., 2015). Moreover, 
another study reported that the phytoestrols of 
Javanese ginseng have an estrogenic activity, in which 
acute consumption of Javanese ginseng extract 
increases cornification and keratinization of the 
vaginal epithelia of the ovariectomized rats in a dose-
dependent manner (Thanamool et al., 2013). 
Phytosterols of Javanese ginseng not only have 
estrogenic activities, but also show androgenic 
potencies (Sulistiono et al., 2017). A study in male 
mice (Mus musculus albinus) demonstrated that the 
root extract of Javanese ginseng given at a dose of 3 
mg/20 g BW increases the number of live 
spermatozoa and decreases the number of abnormal 
spermatozoa; in short, it showed that Javanese 
ginseng has positive effects on spermatogenesis 
(Rahmi et al., 2011). Javanese ginseng also supports 
sperm viability (Sulistiono et al., 2017). In line with 
its androgenic potency, Javanese ginseng has been 
used as an aphrodisiac for a long time (Heyne, 1987; 
Balitbangkes, 2000; Thanamool et al., 2013). It was 
reported that mounting latency was significantly 
lower in Wistar rats that had been given ethanolic 
extracts of Javanese ginseng leaves per oral, when 
compared to the negative control group (Septiani et 
al., 2021). Javanese ginseng also has an effect on the 
neural system. It was demonstrated that ethanolic 
extract of Javanese ginseng root given orally at a dose 
of 12 and 24 mg/rat for 18 days significantly 
increased the thickness of pyramidal lamina of the 
hippocampus of Rattus norvegicus. The hippocampus 
is known for its role in long-term memory (Sari et al., 
2006).  
Javanese ginseng contains several compounds, such 
as phytosterols, steroids, flavonoids, tannins, 
polyphenols, and essential oils. The types of 
phytosterols detected in Javanese ginseng leaves are 
compesterol, β-sistosterol, stigmasterol, stigmastan-3-
ol, stigmast-22-en-3-ol and stigmastanol.  Similar to the 
Asian and American ginsengs, Javanese ginseng also 
contains triterpenoid saponins, which are designated as 
ginsenosides. It was reported that ginsenosides are 
detected in high concentrations in Javanese ginseng 
roots. Types and levels of ginsenosides in Javanese 
ginseng root have been determined using the liquid 
chromatography-mass spectrometry (LC-MS) method. 
The results showed that both hot water and ethanolic 
extract from Javanese ginseng root contains thirteen 
ginsenosides, i.e., ginsenoside K, Rh2, Tg2, Rg3, Rf, 
Rg1, Rd, Re, Ro, Rb2, Rb3, Rc, and Rb1. The order of 
ginsenosides from the highest to the lowest 
concentration in Javanese ginseng root is Rb3, Rb2, 
Rb1, Rc, and Rg1. Meanwhile, Javanese ginseng root 
cultures have been developed to augment the 
production of saponins (including ginsenosides) 
(Manuhara et al., 2015; Santoso et al., 2016; Faizal and 
Sari, 2019).  
Previous studies have shown that ginsenosides have 
been linked to ginseng’s hypoglycaemic effects (Xie et 
al., 2005; Chang et al., 2013; Bai et al., 2018; Chen et 
al., 2019). As Javanese ginseng contains ginsenosides, 
it is thus worthwhile to examine whether or not 
Javanese ginseng can decrease blood glucose levels.    
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MATERIALS AND METHODS  
 
Drugs and Chemicals  
The samples of Javanese ginseng (Talinum 
paniculatum (Jacq.) Gaertn.) used in this study were 
obtained from Boyolali, Central Java, Indonesia. The 
samples had been authenticated in the Integrated 
Research and Laboratory Testing, Universitas Gadjah 
Mada, Yogyakarta. Alloxan monohydrate 
(C4H2N2O4.H20) was purchased from Sigma-Aldrich.  
 
Preparation of Samples 
The roots of the Javanese ginseng (Talinum 
paniculatum (Jacq.) Gaertn.) were sorted in wet 
condition. Then they were washed with running water 
and chopped. The roots were then dried by aerating 
them under sunlight. A black fabric was used to shield 
the simplicia of the roots from excessive damage 
caused by the ultraviolet (UV) light. After that, the 
simplicia were ground into powder using a blender. 
The next step was weighing the powder of the Javanese 
ginseng root as much as 2 g and adds 100 mL of 
distilled water to obtain 2% w/v solution. Then after a 
temperature of 90° C was reached, the solution was 
then heated for another 15 minutes. The solution was 
continuously stirred during the heating. Then the 
solution was filtered with a flannel cloth, and through 
the dregs, hot distilled water was added to the solution 
to obtain the desired infusion volume of 100 mL.  
 
Experiment Animals 
A total of 21 adult male Wistar (Rattus norvegicus) 
rats, 10-12 weeks old, weighing 150-200 g, were 
obtained from the Inter-University Research Center, 
Universitas Gadjah Mada, Yogyakarta. The rats were 
housed in metabolic cages in groups of maximally four 
per cage in a temperature-controlled room (25° C) and 
maintained on a 12:12 hour light/dark cycle. They were 
fed a standard rat chow and water ad libitum, and 




Rats were randomly divided into four groups: 
healthy rats, designated as the negative control group 
(n= 3), that would be given neither injection of alloxan, 
infusion of Javanese ginseng root, nor infusion of 
distilled water; diabetic rats, designated as the positive 
control group (n= 4), that would be given an injection 
of alloxan without an infusion of Javanese ginseng root 
nor infusion of distilled water; diabetic rats, designed 
as the treatment group (n= 7), that would be given an 
injection of alloxan with an infusion of Javanese 
ginseng root; and finally, diabetic rats which were 
designated as the placebo group (n= 7) that would be 
given an injection of alloxan  with an infusion of 
distilled water.  
 
Induction of Diabetes 
All rats, except those in the negative control group, 
were rendered diabetic by intraperitoneal 
administration of alloxan monohydrate (Sigma 
Chemical Co., St Louis, USA) at a single dose of 80 
mg/kg BW in a solution of 0.90% w/v of NaCl. Rats 
showing blood glucose levels > 200 mg/dL after 72 




After the diabetic condition was established, 
infusion of either Javanese ginseng root or distilled 
water (as placebo) was administered to rats in the 
treatment group or placebo group, respectively, at a 
dose of 2% w/v solution with a volume of 1.8 mL/200 
g BW per day for 14 days through an enteral feeding 
tube. 
 
Measurement of Body Weight 
Body weight of rats was measured five times: before 
acclimatization, after acclimatization, after alloxan 
injection, on the 7
th
 day of intervention, and at the end of 
the study, before the rats were euthanized.  
 
Measurement of Blood Glucose Level 
Blood glucose levels were measured three times: 
once after acclimatization, again after the alloxan 
injection, and lastly at the end of study. Blood plasma 
was obtained from the rats’ tails and blood glucose 
levels were measured using the colorimetric glucose 
oxidase-peroxidase (GOD-POD) method.  
 
Ethical Clearance  
All experimental procedures used in this study had 
been approved by the Health Research Ethics 
Committee, Faculty of Medicine, Universitas 
Muhammadiyah Surakarta, with ethical clearance letter 
no. 3232/A.2/KEPK-FKUMS/I/2021.  
 
Statistical Analyses  
A paired t-test was employed to analyze differences 
between pre-test and post-test data. One-way ANOVA 
and Tukey's post hoc analysis were performed to 
analyze differences among groups. The significance 
level was set at P<0.05 and all calculations were 
performed using SPSS version 16.0.   
 
RESULTS AND DISCUSSION 
 
Body Weight 
The results of body weight measurements in Wistar 
rats during this study are presented in Table 1. Body 
weight of the rats was measured before acclimatization, 
after acclimatization, after alloxan injection, on the 7th 
day of intervention, and at the end of the study. 
Measured rats’ body weights obtained after 
acclimatization were used to calculate the dose of 
alloxan injection, while body weights collected after 
alloxan injection and on the 7th day of intervention 
were used to calculate the dose of infusion of Javanese 
ginseng root or distilled water and to adjust the 
calculated dose of infusion of Javanese ginseng root or 
distilled water, respectively.  
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Using one-way ANOVA, there were no significant 
differences in the rats’ body weights among groups, 
namely the negative control, positive control, 
treatment, and placebo, either before (P= 0.127) or after 
(P= 0.185) acclimatization. All rats had increased body 
weight from before acclimatization (194.29±2.99 g) to 
after acclimatization (203.86±3.04 g) (Table 1), thus 
gaining 9.57±0.75 g BW.  
The body weight measured after acclimatization 
was used as the baseline level to calculate the total dose 
of alloxan injection. Not only body weight but also 
blood glucose was measured after acclimatization (see 
below). The dose of alloxan injection was 80 mg/kg of 
the rat’s body weight, which was intraperitoneally 
injected in 0.90% w/v of NaCl solution to the positive 
control, treatment, and placebo group, but not to the 
negative control group. The rats’ body weights as well 
as blood glucose levels (see below) were then measured 
72 hours after alloxan injection.  
Using one-way ANOVA, it was revealed that rats’ 
body weights among groups significantly differed (P= 
0.0001) after the alloxan injection. Using Tukey’ test 
for post hoc analysis, it was shown that rats’ body 
weights in groups that were given an alloxan injection, 
i.e., the positive control (198.25±5.25 g), treatment 
(197.00±2.58 g), and placebo (198.43±3.10 g) group, 
were significantly lower than the negative control 
group (212.00±3.00 g) (P=0.0001) (Table 1). All 
groups given alloxan injection, i.e., the positive control, 
treatment, and placebo (-6.14±3.24 g) group, 
consistently experienced decreased body weights of      
-4.00±0.82 g, -5.86±1.35 g, and -6.14±3.24 g, 
respectively; meanwhile, the negative control group 
that was not given alloxan injection had experienced an 
increased body weight of 5.33±1.15 g. Among those 
groups that were given alloxan injection (the positive 
control, treatment, and placebo group), rats’ body 
weights did not significantly differ (P=0.86-1.00) 
(Table 1).  
During intervention, rats’ body weights were 
measured two times; once in the middle (on 7th day) 
and at the end of the study. In the course of the 
intervention, the treatment group that was given an 
infusion of Javanese ginseng root experienced 
increased body weight from 197.00±2.58 g after the 
alloxan injection to 200.14±2.67 g in the middle of 
intervention and 205.43±2.51 g at the end of the study, 
meaning that the body weight of rats in the treatment 
group had reached that level before the alloxan 
injection (Table 1). A similar pattern of increased body 
weight was also experienced by rats in the negative 
control group, with weights of 212.00±3.00 g after 
alloxan injection, 222.00±2.65 g in the middle of 
intervention, and 231.00±2.00 g at the end of the study. 
Both the positive control and placebo group had, 
however, consistently decreased body weight during 
the course of the study (Table 1).  
 
Blood Glucose Level 
The results of blood glucose measurements in 
Wistar rats during this study can be observed in Table 
2. Using one-way ANOVA, baseline blood glucose 
levels after acclimatization (baseline) did not 
significantly differ (P= 0.57) among groups, i.e., the 
negative control (78.98±1.0 mg/dL), positive control 
(80.64±2.0 mg/dL), treatment (79.83±2.1 mg/dL), and 
placebo (80.58±1.7 mg/dL) group. These results 
showed that these groups were comparable in terms of 
a baseline blood glucose level.   
Blood glucose levels were measured 72 hours after 
the alloxan injection in the positive control, treatment, 
and placebo group as well as in the negative control 
group, which was not given alloxan. Using a paired t-
test, this post alloxan blood glucose level was 
significantly higher than the baseline blood glucose 
level within the positive control (217.88±1.55 vs. 
80.64±2.00 mg/dL; P= 0.0001), treatment (219.74±1.33 
vs. 79.83±2.10 mg/dL; P= 0.0001) and placebo 
(218.54±1.70 vs. 80.58±1.7 mg/dL, P= 0.0001) group. 
Within the negative control group, the second 
measurement of blood glucose level was not 
significantly different from the baseline measurement 
(78.85±0.82 vs. 78.98±1.00 mg/dL; P= 0.58). Using 
one-way ANOVA, post alloxan blood glucose levels 
significantly differed among groups (P= 0.0001). Using 
Tukey’s test for post hoc analysis, post alloxan blood 
glucose levels in the positive control (217.88±1.55 
mg/dL), treatment (219.74±1.33 mg/dL), and placebo 








On the 7th day 
of intervention 




Healthy rats  
(n=3) 
197.33±2.08 206.67±2.08 212.00±3.00 222.00±2.65  231.00±2.00 
Positive 
control  
Diabetic rats given injection 
of alloxan  
(n=4) 
193.00±4.32 202.25±4.57 198.25±5.25 193.25±5.19 190.50±5.07 
Treatment  Diabetic rats given injection 
of alloxan and infusion of 
Javanese ginseng root  
(n=7) 
193.00±2.16 202.86±2.19 197.00±2.58 200.14±2.67 205.43±2.51 
Placebo  Diabetic rats given injection 
of alloxan and infusion of 
distilled water 
(n=7) 
195.00±2.44 204.57±2.57 198.43±3.10 195.43±3.48 192.57±3.82  
P value  0.127 0.185 0.0001** 0.0001** 0.0001** 
**= Significantly difference (P<0.001) using one-way ANOVA. Unit measurement of rat’s body weight was gram (g). Data was presented as 
mean ± standard deviation 
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(218.54±1.70 mg/dL) group were significantly higher 
(P= 0.0001) than in negative control group (78.85±0.82 
mg/dL). There was no significant difference (P= 0.15) 
in post alloxan blood glucose levels among the positive 
control, treatment, and placebo group (Table 2). These 
results showed that a single dose of alloxan could 
significantly increase blood glucose levels in Wistar 
rats.  
Blood glucose levels of post infusion of Javanese 
ginseng root (116.75±1.96 mg/dL) measured at the end 
of the study were significantly lower (P= 0.0001) than 
those of post injection of alloxan (219.74±1.33 mg/dL), 
but were still significantly higher (P=0.0001) than that 
of the baseline level (79.83±2.09 mg/dL). Within the 
placebo group, blood glucose levels of post infusion of 
distilled water (220.99±1.70 mg/dL) were significantly 
higher than those of the post alloxan injection 
(218.54±1.70 mg/dL) (P= 0.0001) and of the baseline 
level (79.83±2.09 mg/dL) (P= 0.0001). Within either 
the negative or positive control group, there were no 
significant differences (P>0.05) among the three 
measures of blood glucose (Table 2).  
Using one-way ANOVA, there was significant 
difference (P= 0.0001) in post intervention blood 
glucose levels among groups. Using Tukey’s test for 
post hoc analysis, it was revealed that blood glucose 
levels in the treatment group after infusion of Javanese 
ginseng root (116.75±1.96 mg/dL) were significantly 
lower from blood glucose levels in the positive control 
(220.93±1.87 mg/dL) (P= 0.0001) and placebo 
(220.99±1.70 mg/dL) (P= 0.0001) group, but was 
significantly higher than in the negative control group 
(80.46±0.65 mg/dL) (P= 0.0001) (Table 2).  
At the end of study, the mean blood glucose level in 
the treatment group was 104.23 mg/dL (95% 
confidence interval (CI) 106.88 to 101.59 mg/dL) 
lower than in the placebo group, 104.17 mg/dL (95% 
CI 107.28 to 101.07 mg/dL) lower than in the positive 
control group, but 36.29 mg/dL (95% CI 32.88 to 39.71 
mg/dL) higher than in the negative control group.  
Delta blood glucose was the gap between post 
intervention and post alloxan blood glucose levels 
(Table 3). Using one-way ANOVA, there was 
significant difference (P=0.0001) in delta blood glucose 
among groups. Using Tukey’s test for post hoc 
analysis, delta blood glucose in the treatment group (-
102.99±2.26 mg/dL) was significantly less (P=0.0001) 
than in the placebo (2.45±0.29 mg/dL), positive control 
(3.05±0.70 mg/dL), and negative control (1.60±0.17 
mg/dL) group.  
At the end of study, blood glucose level reduction 
in the treatment group was 105.43 mg/dL (95% CI 
103.57 to 108.51 mg/dL) greater than in the control 
group, 106.04 mg/dL (95% CI 103.33 to 107.54 
mg/dL) greater than in the positive control group, and 
104.59 mg/dL (95% CI 101.87 to 107.31 mg/dL) 
greater than in the negative control group.  
Plasma glucose levels are pivotal in diagnosing 
diabetes. The American Diabetes Association (ADA) 
has recommended random plasma glucose (RPG), 
fasting plasma glucose (FPG), and oral glucose 
tolerance test (OGTT) to diagnose diabetes. The 
threshold for plasma glucose levels for the diagnosis of 
diabetes is ≥200 mg/dL (11.1 mmol/L) for RPG in a 
person with classic symptoms of hyperglycemia, or 
either ≥126 mg/dL (7.0 mmol/L) for FPG or ≥200 
mg/dL (11.1 mmol/L) for OGTT in a person without 
classic symptoms of hyperglycemia (ADA, 2019).  
Laboratory animals are often used to study diabetes 
experimentally. Rat models of diabetes mellitus can be 
divided into genetic models and chemically induced 
models. In genetic models of diabetic rats, there are 
type 1 diabetes (T1D) models and type 2 diabetes 
(T2D) models. Genetically modified T1D models are 
autoimmune Bio Breeding (BB) rats, which are derived 
from Wistar rats, and LEW 1AR1/-iddm rats, which are 
colonized from Lewis rats. Genetically modified T2D 
models are Zucker Diabetic Fatty (ZDF) rats, which 
developed a mutation in the Leptin receptors, and 
Goto-kakizaki rats, which, like BB rats, are developed 
from Wistar rats. So far, chemically induced diabetic 
rats have been used most frequently in diabetes studies. 
In these models, either streptozotocin (STZ) or alloxan 
is applied to damage the pancreatic β cells (Al-awar et 
al., 2016).  
In this study, alloxan monohydrate was used, which 
is the aqueous solution of alloxan, to induce diabetes in 
Wistar rats. The molecular structure of alloxan is 
Table 2. Blood glucose levels in experiment animals 
Groups 
Baseline 
blood glucose level 
(mg/dL) 
Post alloxan 
blood glucose level 
(mg/dL) 
Post intervention 
blood glucose level 
(mg/dL) 
Negative control  (n= 3) 78.98±1.00 78.85±0.82  80.46±0.65 
Positive control  (n= 4) 80.64±2.02 217.88±1.55 220.93±1.87 
Treatment  (n= 7) 79.83±2.09 219.74±1.33 116.75±1.96 
Placebo      (n= 7) 80.58±1.68 218.54±1.70 220.99±1.70 
Data was presented as mean±standard deviation  
 
Table 3. Delta blood glucose in experiment animals 
Groups 
Delta blood glucose 
(mg/dL) 
Negative control (n=3) 1.60±0.17 
Positive control (n=4)  3.05±0.70 
Treatment (n=7) -102.99±2.26 
Placebo (n=7)  2.45±0.29 
Data was presented as mean±standard deviation 
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similar to glucose and both are hydrophilic. Alloxan as 
well as glucose is transported by a protein carrier, i.e., a 
glucose transporter 2 (GLUT2), to across the lipid 
bilayer of the β cell membrane of the pancreatic islets. 
As alloxan competes with glucose to occupy GLUT2, 
fasted animals are more sensitive to the effects of 
alloxan as compared to fed animals. Alloxan can be 
administered intraperitoneal at a single dose, over a 
dose range of 170-200 mg/kg BW, to induce diabetes 
(Ighodaro et al., 2017). However, it has been proposed 
also to give alloxan at repeated doses to develop 
diabetic animals (Purwanto and Liben, 2002). Alloxan 
builds up reactive oxygen species (ROS), which in turn 
cause partial degradation of the β cells of pancreatic 
islets, therefore causing diminished insulin release. The 
hyperglycemic effect of alloxan can be observed as 
early as 2-4 hours, and it persists 24-48 hours, after its 
administration (Ighodaro et al., 2017). In our study, 
blood glucose levels were measured and the 
hyperglycemic condition was established 72 hours post 
alloxan injection.  A hypoglycemic event could occur 
in experiment animals as early as 30 minutes after 
alloxan exposure. It has been suggested that alloxan 
can induce a massive influx of Ca2+ ions, which 
stimulates an abrupt release of insulin from the β cells 
of pancreatic islets (Ighodaro et al., 2017). In this 
study, there was no hypoglycemic casualty observed in 
the experiment animals after alloxan injection.   
Diabetic hyperglycemia in rats is established when 
the blood glucose level reaches ≥ 200 mg/dL (11.1 
mmol/L) either by chemically induced by STZ or 
alloxan. Moreover, STZ induced diabetic rats can be 
divided into two stages; stage 1 with the blood glucose 
levels 200-450 mg/dL and stage 2 with the blood 
glucose levels 451-750 mg/dL (Qinna and Badwan, 
2015; Ighodaro et al., 2017). In this study, rats given a 
single dose injection of alloxan showed blood glucose 
levels of ≥200 mg/dL, in the positive control 
(217.88±1.55 mg/dL), treatment (219.74±1.33 mg/dL) 
and placebo (218.54±1.70 mg/dL) group (Table 2). 
This means that in this study the intraperitoneally 
injection of alloxan effectively induced hyperglycemic 
diabetes in Wistar rats.  
Regarding the changes in the rats’ body weights, 
this study revealed that: 1) rats’ body weights were 
significantly decreased once hyperglycemic diabetes 
was established; 2) infusion of Javanese ginseng root 
resulted in increased rats’ body weights in the treatment 
group, which reached the level before alloxan injection. 
At the end of study, rats’ body weights in the treatment 
group were comparable to the negative control group; 
3) infusion of distilled water did not change the rats’ 
body weights in the control group, which was 
comparable to the positive control group. Other studies 
also reported a decrease of body mass-as much as 6-
8.17% in STZ-induced Wistar and Sprague-Dawley 
diabetic rats (Nayak et al., 2011, Rias and Sutikno, 
2017). In these studies, however, body weight of 
normal rats showed increased body weight over the 
study period (Nayak et al., 2011; Rias and Sutikno, 
2017). Furthermore, diabetic rats treated with 
glibenclamid, an oral antidiabetic drug, also 
demonstrated increased body weight but the magnitude 
of weight gain in these groups was still below the 
control negative group (Nayak et al., 2011). In a 
clinical setting, weight loss is recognized as one of the 
classic symptoms of type 2 diabetes mellitus (Yang et 
al., 2016). Loss of body weight in diabetes mellitus can 
be caused by increased protein catabolism in the 
skeletal muscles and lipolysis in the adipose tissues in 
order to supply amino acids and free fatty acid, 
respectively, to the liver to proceed the 
gluconeogenesis (Rias and Sutikno, 2017). 
Furthermore, loss of body water caused by osmotic 
diuresis, which is triggered by hyperglycemia, can also 
contribute to a decreased body weight in diabetic 
patients (Yang et al., 2016). Osmotic diuresis can 
increase the osmolarity of the extracellular fluid, which 
in turn stimulates thirst and then polydipsia behavior, 
another classic symptom of diabetes mellitus (Shin et 
al., 2012). Regarding the body weight in the treatment 
group, it had a trend to reach the level before alloxan 
injection and was just below the body weight of the 
negative control group at the end of the study. This 
suggests that insulin resistance has been reduced and 
proteolysis in the skeletal muscles and lipolysis in the 
adipose tissues have been prevented in those rats of the 
treatment group given the infusion of Javanese ginseng 
root (Mathews et al., 2002; Rias and Sutikno, 2017).  
Many studies have examined the hypoglycemic and 
antidiabetic effects of Asian ginseng and American 
ginseng (Xie et al., 2005; Chang et al., 2013; Gui et al., 
2016; Bai et al., 2018; Chen et al., 2019). For example, 
a randomized controlled trial (RCT) for the 
supplementation of Korean red ginseng on 42 subjects 
with prediabetes and newly diagnosed T2DM was 
reported. Prediabetes was defined as subjects who had 
impaired fasting glucose (IFG) (more than 100 mg/dL 
but still below 126 mg/dL) or impaired glucose 
tolerance (IGT) 2 hours following oral glucose 
tolerance test (OGTT) (more than 126 mg/dL but still 
below 200 mg/dL). In that study, supplementation of 
capsules containing 16.58 mg/g total ginsenosides of 
Korean red ginseng as compared to supplementation of 
placebo capsules for 3 times a day in 12 weeks 
effectively decreased fasting serum glucose levels in 
prediabetes and T2DM subjects (Bang et al., 2014). 
Another RCT study on American ginseng showed 
similar results. A gelatinized capsule containing 3 g of 
American ginseng or corn flour as placebo was 
randomly allocated to T2DM group or healthy group in 
one shot. Post prandial capillary glucose levels were 
measured following OGTT 4 hours after the treatment. 
In that study, supplementation of American ginseng 
was shown to significantly reduce post prandial glucose 
levels as compared to the placebo in 10 healthy 
subjects and 9 subjects with T2DM (Vuksan et al., 
2000). Moreover, fermentation in ginseng is getting 
more attention because it increases the amount of small 
ginsenosides, the active form of ginsenosides (Chen et 
al., 2019), which enhances the efficacy of ginseng, 
such as the anti-inflammatory effects (Oh et al., 2014). 
Ikhlas Muhammad Jenie et al. 
 
90 
Regarding fermented ginseng, a RCT was done to 42 
subjects with either prediabetes or type 2 diabetes 
mellitus. These subjects were allocated to either red 
ginseng root extract that had undergone the 
fermentation process using Lactobacillus plantarum or 
placebos containing dried yeast, which was given with 
dose 2.7 g/day for consecutive 28 days. The study 
showed that the fermented red ginseng group had an 
improvement in post prandial insulin and glucose but 
not fasting insulin and glucose levels as compared to 
the placebo group (Oh et al., 2014).  
In this study, the infusion of Javanese ginseng root 
significantly decreased hyperglycemia from 
219.74±1.33 mg/dL to 116.75±1.96 mg/dL in diabetic 
rat models. On the other hand, hyperglycemia persisted 
in both the placebo group and the positive control 
group (Tabel 2). At the end of study, infusion of 
Javanese ginseng root decreased blood glucose levels 
by 102.99±2.26 mg/dL. In contrast, infusion of distilled 
water just increased the rats’ blood glucose levels by 
2.45±0.29 mg/dL (Table 3). To date, this is this first 
study to show that Javanese ginseng root has a 
hypoglycemic effect on diabetic rat models. 
Based on this study, it is advisable that 
ginsenosides, which are detected in the Javanese 
ginseng root (Santoso et al., 2016; Faizal and Sari, 
2019), are used to determine the hypoglycemic effects 
of Javanese ginseng. Ginsenosides, a member of the 
triterpenoid saponins, are mainly responsible for the 
hypoglycemic and antidiabetic effects of Asian ginseng 
and American ginseng (Chang et al., 2013; Santoso et 
al., 2016; Chen et al., 2019). Javanese ginseng roots 
contain ginsenosides Rb3, Rb2, Rb1, Rc, and Rg1 
based on the LC-MS method (Santoso et al., 2016).  
The mechanisms of the antidiabetic effects of 
ginsenosides in the Asian ginseng and the American 
ginseng, as revealed by numerous studies, are exerted 
through peripheral and central action. Peripherally, 
ginsenosides improve insulin resistance. The effects of 
ginsenosides on the liver, such as maintaining normal 
fasting blood glucose levels, are a part of the peripheral 
antidiabetic action of ginsenosides. Centrally, 
ginsenosides protect the β-cells of pancreatic islets 
from apoptosis, thus preserving the function of 
mitochondria in the pancreatic β-cells (Chang et al., 
2013; Bai et al., 2018; Li et al., 2019). As of yet, there 
are no studies that can be found in the literature that 
examine the mechanisms behind the hypoglycemic and 
antidiabetic effects of specific ginsenosides of the 
Javanese ginseng root. 
In this study, the infudation method was used as the 
method of extraction of Javanese ginseng root with 
water, rather than ethanol or oil used as a solvent. 
Triterpenoid saponins such as ginsenosides are actually 
water-soluble (Brain and Turner, 1975). It has been 
shown that the types of ginsenosides detected in 
Javanese ginseng root which have been extracted with 
hot water are similar to those extracted with ethanol 
(Faizal and Sari, 2019). Moreover, the infudation 
method is in concordance with the way people on the 
island of Java, Indonesia, have traditionally  prepared 
Javanese ginseng root as a medicine, which is by 





In conclusion, Javanese ginseng root has potential 
as a hypoglycemic agent in alloxan-induced diabetic 
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